M. Teresa Tejedor

Dr. M. Teresa Tejedor

Dept. Anatomy, Embriology and Genetics, Veterinary Faculty, Universidad de Zaragoza ( Spain)
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
DTDiego Tejedor
Diego Tejedor
SCSergio Castillo
Sergio Castillo
PMPilar Mozas
Pilar Mozas
EJElisa Jiménez
Elisa Jiménez
MLMónica López
Mónica López
SGSpanish FH Group
Spanish FH Group
Background: Patients with familial hypercholesterolemia (FH) have a high risk of premature cardiovascular disease (PCVD). Mutations in the LDL receptor (LDLR) gene and the R3500Q mutation in the apolipoprotein B (APOB) gene are known to cause FH, but lack of high-throughput methods makes routine genetic diagnosis difficult. The objective of this work was to develop a DNA array for large-scale identification of mutant LDLR alleles.

1 May 2016 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
ACAna Cenarro
Ana Cenarro
AEAitor Etxebarria
Aitor Etxebarria
ICIsabel de Castro-Orós
Isabel de Castro-Orós
MSMarianne Stef
Marianne Stef
ABAna M. Bea
Ana M. Bea
FCFernando Civeira
Fernando Civeira
Context: The p.Leu167del mutation in the APOE gene has been associated with hyperlipidemia.Objectives: Our objective was to determine the frequency of p.Leu167del mutation in APOE gene in subjects with autosomal dominant hypercholesterolemia (ADH) in whom LDLR, APOB, and PCSK9 mutations had been excluded and to identify the mechanisms by which this mutant apo E causes hypercholesterolemia.Design: The APOE gene was analyzed in a case-control study.Setting: The study was conducted at a University Hospital Lipid Clinic.Patients or Other Participants: Two groups (ADH, 288 patients; control, 220 normolipidemic subjects) were included.Intervention: We performed sequencing of APOE gene and proteomic and cellular experiments.Main Outcome Measure: To determine the frequency of the p.Leu167del mutation and the mechanism by which it causes hypercholesterolemia.Results: In the ADH group, nine subjects (3.1%) were carriers of the APOE c.500_502delTCC, p.Leu167del mutation, cosegregating with hypercholesterolemia in studied families. Proteomic quantification of wild-type and mutant apo E in very low-density lipoprotein (VLDL) from carrier subjects revealed that apo E3 is almost a 5-fold increase compared to mutant apo E. Cultured cell studies revealed that VLDL from mutation carriers had a significantly higher uptake by HepG2 and THP-1 cells compared to VLDL from subjects with E3/E3 or E2/E2 genotypes. Transcriptional down-regulation of LDLR was also confirmed.Conclusions: p.Leu167del mutation in APOE gene is the cause of hypercholesterolemia in the 3.1% of our ADH subjects without LDLR, APOB, and PCSK9 mutations. The mechanism by which this mutation is associated to ADH is that VLDL carrying the mutant apo E produces LDLR down-regulation, thereby raising plasma low-density lipoprotein cholesterol levels.

1 January 2009 in Animal Reproduction Science
Verified
Journal Article
Closed access
LMLuis Monteagudo
Luis Monteagudo
RPRicardo Ponz
Ricardo Ponz
MTM. Teresa Tejedor
M. Teresa Tejedor
ALAdolfo Laviña
Adolfo Laviña
ISIsidro Sierra
Isidro Sierra

Verified
Journal Article
Open access
PDF file
CMCRISTINA MATOVELLE
CRISTINA MATOVELLE
MTM. Teresa Tejedor
M. Teresa Tejedor
LMLuis Monteagudo
Luis Monteagudo
ABAntonio Beltrán
Antonio Beltrán
Joaquin QuilezJoaquin Quilez
Joaquin Quilez
Blastocystis sp. is known to be the most prevalent parasite in fecal samples of humans worldwide. In the present report, a case–control study (1:9.89 (≈10)) was performed, by analyzing data from 3682 patients who attended a public hospital in the northern area of Spain showing gastrointestinal symptoms. Diagnosis was performed in human fecal samples by means of optical microscopy. The prevalence of Blastocystis sp. in patients with gastrointestinal symptoms was 9.18% (338/3682). Most of the Blastocystis sp.-infected patients tested negative for protozoa and helminths, and were underweight and foreign-born (26.4%), mainly from Africa and Central/South America. Gastrointestinal symptoms, such as abdominal pain, anorexia, halitosis, plus relative eosinophilia, as well as co-infections with pathogenic bacteria were associated with Blastocystis sp. infection. Both type 2 diabetes and treatment with immunosuppressive medicines at the time of Blastocystis sp. detection were associated with a higher proportion of infected patients. This is the first case–control study of Blastocystis sp. in humans in northern Spain and may contribute to surveillance and intervention strategies by public health authorities.

6 November 2003 in Pigment Cell Research
Verified
Journal Article
Closed access
PDF file
DVDag Inge Våge
Dag Inge Våge
MFMalcolm R. Fleet
Malcolm R. Fleet
RPRicardo Ponz
Ricardo Ponz
RORanveig T. Olsen
Ranveig T. Olsen
LMLuis Monteagudo
Luis Monteagudo
HKHelge Klungland
Helge Klungland

30 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTM. Teresa Tejedor
M. Teresa Tejedor
MGMaria Pilar Garcia-Sobreviela
Maria Pilar Garcia-Sobreviela
MLMarta Ledesma
Marta Ledesma
José Miguel Arbones-MainarJosé Miguel Arbones-Mainar
José Miguel Arbones-Mainar
The apolipoprotein E (APOE) gene is polymorphic, encoding one of 3 common alleles (ε2, ε3, ε4) produced from combinations of 2 non-synonymous SNPs (rs429358 and rs7412). APOE plays an important role controlling plasma lipids but its association with adipocyte functionality and body fatness remains to be determined. We analyzed fasting plasma lipids and genotyped the two main APOE-SNPs (rs429358 and rs7412), both located in the fourth exon of the APOE, in 4660 Caucasian middle-aged men free of cardiovascular disease. The rs7412 SNP, which determines the APOE2 isoform, was significantly associated with Body Mass Index (BMI) and Waist Girth (WG) in a multivariate model accounting for age, smoking status and plasma lipids. BMI and WG were highest in TT homozygotes and lowest in CC homozygotes. This effect was independent of the rs429358 SNP, which failed to show any association with the BMI and WG variables. The odds ratio of being obese (BMI>30) for individuals carrying the APOε2 allele, present in 14% of the cohort and defined by the rs7412 SNP, was also significant in this multivariate model, with an OR of 1.27 (95% CI: 1.01–1.59). This study provides an evidence of a lipid-independent association between the APOE SNP rs7412 and body fatness surrogates, BMI and WG, in a large cohort of middle-aged males.